Oncorus Inc reports results for the quarter ended in September - Earnings Summary
Brief: Oncorus Reports Third Quarter 2022 Financial Results
Oncorus Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Oncorus Q2 Loss Per Share Of $0.74
Oncorus Inc expected to post a loss of 72 cents a share - Earnings Preview
Brief: Oncorus Announces Appointment Of Richard Wanstall As Chief Financial Officer
Oncorus Inc reports results for the quarter ended in March - Earnings Summary
Brief: Oncorus Reports First Quarter 2022 Financial Results
Oncorus Inc expected to post a loss of 77 cents a share - Earnings Preview
Brief: Oncorus Announces Debt Capital Facility With K2 Healthventures With $20 Million Funded At Closing
Brief: Oncorus Inc Says On March 15, John Mccabe Notified His Intention To Resign As CFO And Treasurer Of Company Effective April 1
Oncorus Inc reports results for the quarter ended in December - Earnings Summary
Brief: Oncorus Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Updates
Oncorus Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Oncorus Files Prospectus Supplement Related To Sales Of Shares Having Offering Price Of Up To $50 Mln
Brief: Oncorus Reports Data From Its Ongoing Phase 1 Clinical Study Of ONCR-177, At SITC 2021
Brief: Oncorus Announces Exclusive Licensing Agreement With Gaeta Therapeutics Ltd
Brief: Oncorus Inc Files For Mixed Shelf Of Up To $200 Million
Brief: Oncorus Reports Q3 2021 Financial Results And Provides Business Updates